Can Pneumothorax Developing in COVID-19 Patients be a Mortality Marker?
Küçük Resim Yok
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Objectives: The purpose of this study is to investigate the effects of pneumothorax (PX), a rare complication of COVID-19, on mortality. Methods: All patients admitted to our hospital with the diagnosis of COVID-19 were screened, and patients who developed PX were includ- ed in the study. Patient demographics data, number of days of hospital- ization for comorbidities, day and duration of thorax tube insertion, and laboratory findings during hospitalization were recorded by scanning the hospital automation system and patient records. Results: For our study, 7485 patients hospitalized with the diagno- sis of COVID-19 were screened in intensive care unit. PX was de - tected in 32 (0.296%) of the patients. About 59.4% of these patients included in the study were male. DM was the most common co - morbid condition at 56.3%. In these patients, the mortality rate was found to be 90.6%. Conclusion: The data obtained indicate that PX, a COVID-19 complica- tion, leads to a serious increase in mortality. We believe that using pro- tective ventilation methods to avoid the development of pneumotarax will help to reduce mortality.
Açıklama
Anahtar Kelimeler
Solunum Sistemi, Sağlık Politikaları ve Hizmetleri, Acil Tıp, Temel Sağlık Hizmetleri, Yoğun Bakım, Tıp
Kaynak
Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
28
Sayı
4
